The vasoactive intestinal peptide (VIP) has been located in various structures of the rat brain, but few actions of the peptide have been reported as yet. Because VIP might interact with classical neurotransmitter systems in the central nervous system as it does in the periphery, we investigated whether VIP can modulate serotonin (5-HT,) receptors in membrane preparations obtained from brain areas which contain various amounts of VIP and 5-HT receptors. The presence of bacitracin alone, which protects VIP from proteolytic degradation, decreases the affinity of ["HI5-HT binding in almost all of the structures tested. Scatchard analysis indicates that, in the presence of bacitracin, VIP significantly decreases the affinity and increases the number of specific high affinity binding sites for ["HI5-HT in the dorsal hippocampus. VIP induces a dose-dependent increase in the number of 5-HT, receptors with a maximal response of 60% with lo-' M VIP. At the same concentration, neither secretin nor glucagon modifies 5-HT, receptor density. No effect of VIP is observed in the ventral hippocampus, parietal cortex, whole hypothalamus, and midbrain. This effect of VIP is not observed when bacitracin is omitted, and the presence of calcium ions does not alter the efficacy of the VIP effect. No effect of VIP is obtained on ["Hlspiperone binding assayed with 10 PM mianserin to define specific binding. The present data suggest that some of the effects of 5-HT in the hippocampus may be modulated by VIP.
and Pert, 1979; Staun-Olsen et al., 1982) coupled to adenylate cyclase (Deschodt-Lanckman et al., 1977; Quik et al., 1978; Borghi et al., 1979) , attributes a possible neurotransmitter function to VIP in the CNS. However, specific functions of VIP in the CNS are not well documented. VIP has been shown to induce excitation of cortical neurons (Phillis et al., 1978) , glycogenolysis in mouse cortical slices (Magistretti et al., 1981) , and vasodilatation of cerebral blood vessels (Larsson et al., 1976a) .
Serotonin (5-HT)-positive nerve terminals originating from the midbrain raphe nuclei have been shown to innervate various forebrain regions such as the cortex, the hippocampus, and the hypothalamus (Steinbusch, 1981) . Moreover, those structures, as well as the midbrain, have been shown to contain high to moderate amounts of 5-HT receptors (Peroutka and Snyder, 1981; Biegon et al., 1982) . Therefore, the present study was designed to test whether VIP can modulate the binding of 5-HT to membranes from various brain areas.
Materials and Methods
Male Sprague-Dawley rats (220 to 240 gm, Charles River Breeding Laboratories, Wilmington, MA) were 2414 used. The animals were killed between 9:00 and 11:00 AM (light/dark cycle: 5.00 to 19.00, lights on) by decapitation, and various brain regions such as dorsal and ventral hippocampus, parietal cortex, whole hypothalamus, and pontine regions of the midbrain were rapidly dissected on ice and kept frozen at -70°C. Membrane preparation and assay procedure are based on the method of Bennett and Snyder (1976) as modified by Nelson et al. (1978) and Biegon and McEwen (1982) . In brief, frozen tissues were thawed and homogenized in 50 mM Tris-HCl buffer, pH 7.6, in a glass-Teflon homogenizer (Arthur H. Thomas Co., Philadelphia, PA). The homogenate was centrifuged at 30,000 X g for 15 min, washed with buffer, homogenized with a Brinkmann Polytron (setting 7, for 10 set), and centrifuged again. After two washes, the membrane pellet was resuspended in 50 mM Tris-HCl buffer and incubated for 10 min at 37°C to facilitate destruction of endogenous 5-HT monoamine oxidase. The membranes were then centrifuged for 10 min at 30,000 x g, and the supernatant was discarded and replaced by an equal volume of 50 mM Tris-HCl buffer, pH 7.4, containing 0.2 mg/ml of ascorbate and lop4 M pargyline (Saber Laboratories, Morton Grove, IL). The membrane preparation was homogenized with a Polytron (5 set) and preincubated for 45 min at 25°C under agitation in the presence or absence of bacitracin (2 x lo-" M; Sigma Chemical Co., St. Louis, MO) plus or minus various concentrations of VIP. Incubation was performed for 10 min at 37°C in the presence of increasing concentrations of ["H]5-HT (New England Nuclear, Boston, MA; 27 to 30 Ci/mmol; 0.6 to 6 nM; 0.25 ml), 0.5 ml of tissue homogenate (100 to 500 pg of protein/sample), and 0.25 ml of buffer or 20 PM (5 PM final) unlabeled 5-HT (Sigma) to evaluate nonspecific binding. The incubation reaction was terminated by transferring the tubes to an ice water bath. Tissues were then filtered through Whatman GF/B glass fiber filters using a Brandel Cell Harvester (Brandel Instruments, Gaithersburg, MD). Filtration was followed by three 2-set washes with ice-cold buffer, 2 set apart (which is equivalent to 10 ml). Filters were placed in scintillation vials containing 5 ml of Liquiscint (National Diagnostics, Inc., Somerville, NJ), incubated for 10 min at 5O"C, and then cooled and counted in a P-scintillation counter at 32% efficiency. in terms of B,,, and Kn, are similar to those already reported (Bennett and Snyder, 1976; Nelson et al., 1978; Biegon and McEwen, 1982) , and the pharmacological specificity of the assay was previously validated in our laboratory (Biegon and McEwen, 1982) .
Effect of bacitracin on 5-HT binding. The presence of bacitracin (2 x lo-" M), a proteolytic inhibitor (Desbuquois and Cuatrecasas, 1972; McKelvy et al., 1976) in the pre-and incubation medium induces a significant increase in the Kn for ["HI5-HT, e.g., a decrease in the affinity for the ligand and no change in the number of binding sites. The same tendency is observed in the dorsal hippocampus, but it is not significant ( Table I) .
Effect of VIP on 5-HT binding in various brain structures. Binding of ["H]5-HT to membranes from the ventral hippocampus (control Kn, 4.9 f 0.8 nM; 616 f 92 fmol/mg of protein versus VIP Ku, 5.9 + 0.4; B,,,, 702 f 97 (6)), the parietal cortex (5.7 + 0.6; 426 f 31 versus 6.7 f 0.3; 508 f 55(3)), the whole hypothalamus (6.4 + 0.6; 692 + 38 versus 7.2 + 1.5; 630 + 37(3)), and the pontine formation of the midbrain (5.8 Ifl 0.1; 521 + 56 versus 7.1 + 0.5; 505 f 80(3)) is not affected by lo-' or 2 X lo-' M VIP. In contrast, as shown in Figure 1 (4)). This effect of VIP can be observed only if bacitracin is present in the incubation medium (Fig. 2) .
Dose response of VIP on 5-HT biding in the dorsal hippocampus. VIP, at concentrations ranging from 3 X lo-' M to 10-7M, produces a dose-dependent increase in ["H]&HT-specific binding in the dorsal hippocampus with a maximum increase of approximately 60% at IO-'M VIP. The effect declines at higher concentrations of the peptide (Fig. 3) .
Specificity of the effect of VIP in the dorsal hippocampus. Other peptides, such as secretin and glucagon, which share structural analogies with VIP (Said and Mutt, 1972), do not modify the number of 5-HT-binding sites at an identical concentration of VIP (10e7~) which produces the maximum effect. However, secretin at that concentration appears to decrease the affinity of ["HI5 HT binding in the dorsal hippocampus (Fig. 4) .
Effect of calcium on VIP-induced increase of 5-HT binding. Because calcium ions have been reported recently to increase the number of 5-HT-binding sites (Mallat and Hamon, 1982), we tested whether the effect of VIP can be modified by the presence of calcium ions in the incubation medium. As shown in Figure 5 , the presence of 4 mM CaC12 dramatically increases the number of binding sites for [3H]5-HT in the dorsal hippocampus concomitant with a slight increase in the affinity. However, the efficacy of VIP to increase 5-HT,-specific binding is not affected by the presence of calcium.
Effect of VIP on PHlspiperone binding in the dorsal hippocampus. In contrast to the effect of VIP on [3H]5-HT binding, the binding of ["Hlspiperone in the dorsal hippocampus is not modified by identical amounts of VIP (data not shown). secretin has been shown to inhibit the binding of [12sI] VIP but with affinities %OO to %ooo those of unlabeled VIP (Robberecht et al., 1978; Prieto et al., 1979; Taylor and Pert, 1979) , further studies may be able to show that much higher concentrations of secretin may mimic the effect of VIP on ["H]&HT binding. Whether that has any physiological significance remains to be determined.
The dose response concentration of VIP to increase specific binding for 5-HT in the dorsal hippocampus is in good agreement with effective doses of VIP, which have been shown to produce a physiological effect; for instance, on both cyclic AMP accumulation and prolactin release from pituitary cells (Rotsztejn et al., 1980 (Rotsztejn et al., , 1981 , a maximum effect of VIP is observed with 10m7 M VIP. A biphasic effect of VIP obtained with increasing concentrations of VIP has already been observed on cyclic AMP productin in a human prolactin-secreting Bennett and Snyder, 1976; Nelson et al., 1978; Taylor \ and Pert, 1979; Mallat and Hamon, 1982) . Our data (1980) observed that fatty acids were able to increase both membrane viscosity and high affinity binding sites for ["H]5-HT. Such a change in lipid membrane properThe effect of VIP seems to be mediated by specific ties might also explain the alteration of their affinity for VIP receptors, since they have been found in high con-["H]5-HT binding caused by bacitracin, a peptidergic centrations in the hippocampus (Taylor and Pert, 1979) , and other peptides such as secretin and glucagon, strucantibiotic. However, more work is needed to clarify this point. The increase of 5-HT1-binding sites induced by turally related to VIP (Said and Mutt, 1972) , do not VIP in the dorsal hippocampus is observed only in the produce any significant change in the number of 5-HT,-binding sites at concentrations similar to those for VIP.
presence of bacitracin; this can be related to a previous observation showing that bacitracin prevents the degraHowever, it is interesting to note that, like VIP, secretin dation of VIP and glucagon by liver membranes (Desappears to decrease the affinity for 5HT1 biding. Since buquois et al., 1973; Bataille et al., 1974).
The dorsal hippocampus receives a large 5-HT innervation (Azmitia and Marovitz, 1980; Kohler et al., 1981) and contains high amounts of 5-HT and VIP receptors (Taylor and Pert, 1979; Biegon et al., 1982) . Both 5-HT and VIP have been shown to influence electrical activity in this brain region (Dodd et al., 1979; Jahnsen, 1980; Segal, 1980) . It has been recently observed that VIP may have some hypnogenic properties in rats by increasing paradoxical sleep duration; moreover, VIP can counteract insomnia induced by parachlorophenylalanine treatment (Riou et al., 1981) . It may be suggested that the modulation by 5-HT of sleep-wakefulness states (Jacobs and Jones, 1978) can be influenced by VIP.
Finally, the subiculum, where the interaction between the VIP and 5-HT receptors has been visualized by quantitative autoradiography (Rostene et al., 1983) , has been shown to be an important relay structure which collects information coming from other parts of the hippocampus and sends it to other brain regions (Meibath and Siegel, 1977) . In view of this, the present data suggest that VIP effects through the 5-HT, receptor may be of special significance for the hippocampal influence on the rest of the brain.
